Blood transfusion for acute decompensated heart failure-friend or foe?

Moshe Garty, Eytan Cohen, Alexander Zuchenko, Solomon Behar, Valentina Boyko, Zaza Iakobishvili, Moshe Mittelman*, Alexander Battler, Avraham Shotan, Shmuel Gottlieb, Avraham Caspi, David Hasdai

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background: In acute coronary syndromes (ACSs), blood transfusion (BT) has been associated with worse outcomes. The impact of BT among patients with acute decompensated heart failure (ADHF) remains unknown. Methods: Propensity score analysis of patients with ADHF with and without BT in a national heart failure (HF) survey was used in this study. Results: Of the 4,102 enrolled patients, 2,335 had ADHF, of whom 166 (7.1%) received BT. These patients were older (75.6% vs 73.6%, P = .04), more likely to be females (54.8% vs 43.9%, P = .007), more likely to have diabetes (59.0% vs 51.1%, P = .04) and renal dysfunction (59.0% vs 40.2%, P < .001), and more likely to receive inotropes (16.9% vs 8.0%, P < .001), but they had similar rates of ACS (41.0% vs 39.4%, P = .69) and prior HF (64.5% vs 70.0%, P = .23). Nadir hemoglobin levels were commonly <10 g/dL in BT patients (92.7% vs 8.0%); 15 BT patients had bleeding complications, of which 10 are major bleeding. Major predictors for BT were ACS (OR 1.85, 95% CI 1.15-2.96), inotropes use (OR 2.36, 95% CI 1.22-4.55), and nadir hemoglobin (OR 0.18 per 1 g/dL increase, 95% CI 0.14-0.22). In-hospital, 30-day, 1-year, and 4-year unadjusted mortality rates were higher for BT patients (10.8% vs 5.2%, P = .02; 11.0% vs 8.5%, P = .27; 39.6% vs 28.5%, P = .03; 69.5% vs 59.5%, P = .01, respectively). However, in 103 propensity-matched pairs (c-statistic 0.97), short-term mortality tended to be lower with BT (8.7% vs 14.6%, P = .20; 9.7% vs 18.4%, P = .08; 38.8% vs 42.7%, P = .59; and 72.8% vs 76.7%, P = .52, respectively). Conclusions: Acute decompensated HF patients receiving BT had worse clinical features and unadjusted outcomes, but BT per se seemed to be safe and perhaps even beneficial.

Original languageEnglish
Pages (from-to)653-658
Number of pages6
JournalAmerican Heart Journal
Volume158
Issue number4
DOIs
StatePublished - Oct 2009

Fingerprint

Dive into the research topics of 'Blood transfusion for acute decompensated heart failure-friend or foe?'. Together they form a unique fingerprint.

Cite this